EWEthan Wainman

Ethan Wainman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ethan Wainman has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuropathologic Correlates of Cognitive Functions in Patients With Essential Tremor Without Dementia

    by Stephanie A. Cosentino, Silvia Chapman, Tomer Ori Guy, Sandra Rizer, Diane S. Berry, Ethan Wainman, Nora C. Hernandez, Edward D. Huey, Phyllis L. Faust, Elan D. Louis

  • Estimates of Incidence and Prevalence of Conversions to Mild Cognitive Impairment and Dementia in Patients With Essential Tremor

    by Diane S. Berry, Tomer O. Guy, Ericka D. Carter, Ethan Wainman, Nora C. Hernandez, Vibhash D. Sharma, Edward D. Huey, Stephanie A. Cosentino, Elan D. Louis

    Background and ObjectivesIt is increasingly recognized that cognitive decline is a feature of essential tremor (ET). However, studies of the prevalence, incidence, and annual conversion proportions...


  • Open Access

    Perceptual and Acoustical Features of Dysarthria in Essential Tremor: An Observational Study that Expands the Cerebellar Features of Essential Tremor

    by Nayanika Ghosh, Nora Hernandez, Ethan Wainman, Isabella Forestieri, Elan D. Louis, Rosemary A. Lester-Smith

    Background: Clinical, neuroimaging and postmortem studies indicate cerebellar dysfunction in essential tremor (ET). Clinically this is reflected in intention tremor, gait ataxia, and impaired motor timing. However, the effect of cerebellar dysfunction on speech in ET remains unclear, and research on dysarthria in ET is limited. This study aimed to 1) identify the perceptual features of dysarthria in ET, 2) verify the prominent perceptual features using acoustical analyses, and 3) determine the percentage of participants exhibiting hyperkinetic, ataxic or mixed hyperkinetic-ataxic dysarthria. Methods: Speech samples from fifteen participants with ET were analyzed. An expert rater completed auditory-perceptual ratings, and acoustical analyses were completed that corresponded to perceptual features detected in participants’ speech, including speech timing, prosody, and voice quality measures. Results: Perceptual analyses revealed slow and variable speech rate, prolonged interword intervals and phonemes, imprecise consonants, distorted vowels, hypernasality, vocal tremor, harshness, breathiness, hoarseness, reduced loudness, and excess loudness variation in more than 50% of the participants. Acoustical analyses confirmed the presence of vocal tremor as well as numerically lower articulation rate, longer and more variable syllable duration, and lower smoothed cepstral peak prominence in more than 50% of participants compared to normative data from prior studies. Acoustical analyses classified one participant as ataxic and 14 participants as mixed hyperkinetic-ataxic. Discussion: This study revealed the presence of cerebellar signs of dysarthria in speakers with ET, primarily supporting a mixed hyperkinetic-ataxic dysarthria profile in ET. The data indicate that cerebellar dysfunction in ET does not spare speech and voice.

  • Neuropathologic Changes in People With Essential Tremor With Dementia

    by Ethan Wainman, Diane S. Berry, Nora C. Hernandez, Tomer Ori Guy, Stephanie A. Cosentino, Phyllis L. Faust, Elan D. Louis

    Prospective cohort studies have demonstrated elevated risks of incident dementia in patients with essential tremor (ET). The explanation for this enhanced risk of dementia in ET is unknown. We aimed to elucidate the underlying neuropathologic features of ET-dementia. In a 10-year, prospective cohort study of cognition in ET, we followed participants with detailed neuropsychological testing (assessing 5 primary domains) and assigned cognitive diagnoses (normal cognition, mild cognitive impairment [MCI], or dementia) by expert consensus; brains were collected at death. Participants resided in 43 US states. The detailed neuropathologic assessment included a Braak neurofibrillary tangle stage, Braak Lewy pathology stage, Thal β-amyloid score, and neuritic plaque score. The overall level of Alzheimer disease neuropathologic changes (ADNCs) was reported using the "ABC" scale. Other tauopathies and comorbid cerebrovascular pathologies were diagnosed. During statistical comparisons, we stratified each of the above neuropathologic features into 2 categories: high vs low. We examined how neuropathologic findings mapped onto cognitive diagnoses. The 381 participants yielded 86 brains (mean age at death 90.1 years, 55.8% female). Participants with ET-dementia (n = 40) had higher odds of having severe AD-type pathologies than ET-NC (n = 30): advanced Braak AD stage odds ratio (OR) = 22.8, Thal score OR = 8.0, Consortium to Establish a Registry for Alzheimer Disease score OR = 5.7, and ADNC score OR = 21.1; cerebral amyloid angiopathy scores were also higher (OR = 4.3) (all p ≤ 0.01). Participants with ET-MCI (n = 16) demonstrated intermediate neuropathology, with greater odds of higher Braak AD stages than those with ET-NC (OR = 8.0, p = 0.009). Other neuropathologies were similar across cognitive groups. Our neuropathologic description of ET-dementia shows that, in this sample of 40 participants with ET-dementia, Alzheimer pathology is the prime driver of marked cognitive impairment in ET. Further studies are needed to refine our understanding of the nature of tau aggregation in ET and the extent to which this is similar to or diverges from that seen in AD. One implication of the current finding, which is a more direct link between ET and AD, is that this opens the door to blood-based biomarker testing in individuals with ET who are experiencing cognitive difficulties.